Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Abbott closes 3 clinical trials for disappearing drug-eluting coronary stent
Tendyne Holdings secures $25M for transcatheter mitral valves
Medtech startup Tendyne Holdings landed $25 million in Series C funding, planning on using the new cash for further research & development of its transcatheter mitral valve technology.
The 4-year-old company’s device provides minimally invasive treatment of mitral regurgitation. Tendyne is working on engineering an implantation system that would allow physicians to re-position or retrieve the valve even after full deployment.
Over-stenting doc costs bosses $37M in patient complaints | MassDevice.com On Call
MASSDEVICE ON CALL — A years-old over-stenting dispute is coming to a head as the former owner of St. Joseph Medical Center in Maryland agreed to pay up to $37 million to resolve patient lawsuits.
Boston Scientific’s lead-free S-ICD heads to Asia
Massachusetts medical device giant Boston Scientific (NYSE:BSX) is taking its S-ICD lead-free cardiac implant on tour, reaching new regions in Asia Pacific.
ReliantHeart goes head-to-head with Thoratec to aim for U.S. LVAD market
Edwards Lifesciences lands E.U. approval for INTUITY Elite aortic valve
Edwards Lifesciences (NYSE:EW) announced today that it won CE Mark approval in the European Union to market its next-generation INTUITY Elite aortic valve.
ACC 2014: Conflicts in renal denervation, competition in valves
The American College of Cardiology’s annual Scientific Sessions are regularly a source of controversy and competition, but medtech titan Medtronic’s (NYSE:MDT) highly anticipated renal denervation study results may have been the most confounding.
Thoratec recall gets FDA’s highest-risk label following injuries, deaths | MassDevice.com On Call
Sorin wins expanded CE Mark for Perceval aortic valve
Sorin Group (BIT:SRN) said it won CE Mark approval in the European Union for adult patients to be treated with its Perceval sutureless aortic valve.
ACC 2014 Roundup: Study shows long-term benefits for some CRT-D patients
Some patients with mild heart failure show significant, long-term benefits from cardiac-resynchronization therapy, according to the 7-year results from Boston Scientific‘s (NYSE:BSX) MADIT-CRT clinical trial presented at the American College of Cardiology’s annual meeting over the weekend.